Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

InspireMD Inc. - Common Stock (NQ:NSPR)

2.110 -0.180 (-7.86%)
Streaming Delayed Price Updated: 2:05 PM EST, Nov 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about InspireMD Inc. - Common Stock

< Previous 1 2 3 Next >
InspireMD Inc (NSPR) Q3 2025 Earnings Top Estimates, Fueled by Strong Sales Beat
InspireMD (NSPR) Q3 2025 results beat revenue estimates by 40%, driven by the successful U.S. launch of its CGuard Prime carotid stent system. 
Via Chartmill
Earnings Scheduled For November 4, 2025
 
Via Benzinga
Earnings Scheduled For August 5, 2025
 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Unusual volume stocks are being observed in Wednesday's session.
The trading volume of these stocks is deviating from the norm in today's session. 
Via Chartmill
A Look Ahead: InspireMD's Earnings Forecast
 
Via Benzinga
Earnings Scheduled For November 12, 2024
 
Via Benzinga
Preview: InspireMD's Earnings
 
Via Benzinga
Earnings Scheduled For November 6, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Why BlackBerry Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
InspireMD Stock Dips On Wider-Than-Expected Q1 Loss, But Retail Is Optimistic
The company’s revenue increased marginally to $1.52 million, driven by the continued adoption of its CGuard technology in existing markets. 
Via Stocktwits
InspireMD Earnings Preview
 
Via Benzinga
Why Are InspireMD Shares Surging Today
 
Via Benzinga
Earnings Scheduled For May 9, 2025
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
NSPR Stock Earnings: InspireMD Misses EPS, Misses Revenue for Q2 2024
NSPR stock results show that InspireMD missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Earnings Scheduled For March 12, 2025
 
Via Benzinga
NSPR Stock Earnings: InspireMD Misses EPS, Beats Revenue for Q1 2024
NSPR stock results show that InspireMD missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
NSPR Stock Earnings: InspireMD Beats EPS, Beats Revenue for Q4 2023
NSPR stock results show that InspireMD beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market. 
Via Benzinga
Earnings Scheduled For March 6, 2024
Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 12, 2023
 
Via Benzinga
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash. 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.